You just read:

Janssen Submits Applications Requesting Approval Of SIMPONI® In U.S. And Europe For Treatment Of Moderately To Severely Active Ulcerative Colitis

News provided by

Janssen Research & Development, LLC

16 Jul, 2012, 21:05 BST